Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Newly Nominated Surgeon General Will Need To Talk More Openly About HIV/AIDS, Opinion Piece Says
Newly nominated Surgeon General Regina Benjamin has a "tall order" ahead of her being "[c]hief health educator" of the U.S., "and, if confirmed, she will have to talk to us all in terms we plainly understand," Lorraine Teel, executive director of the Minnesota AIDS Project, writes in a Minneapolis Star Tribune opinion piece. She adds, "But when it comes to unintended pregnancies, sexually transmitted diseases and AIDS, the message becomes more difficult" than messages related to nutrition and obesity. Teel says that "former Surgeon Generals tried to educate us," on HIV/AIDS, such as Surgeon General C. Everett Koop, but he "was prevented from speaking frankly." Teel continues, "Let"s hope that this Surgeon General"s administration sounds the alarm, loud and clear, about HIV. A major factor in why we are not winning the battle against AIDS is because we have been forced to only politely talk about risk" (7/1).

Foresight Biotherapeutics Announces FST-100 Displays Robust Clinical Improvement In Adenoviral Conjunctivitis Model
Foresight Biotherapeutics, Inc. announced data from a pre-clinical study designed to assess the safety and efficacy of the topical administration of FST-100 in a highly regarded Ad5 NZW rabbit model of adenoviral conjunctivitis. FST-100 demonstrated a clinically and statistically significant reduction in signs of adenoviral conjunctivitis versus all other groups including the current experimental "gold standard", topical cidofovir. The study was conducted at the Louisiana State University (LSU) Health Science Center, LSU Eye Center in New Orleans, Louisiana by Professor James M. Hill and colleagues, in the Departments of Pharmacology, Microbiology, Ophthalmology and Neuroscience.
News of the day
ANA Eager For Debate On Healthcare Reform Bill Introduced In Senate
The American Nurses Association (ANA) eagerly awaits the imminent debate prompted by the Affordable Health Choices Act, introduced in the U.S. Senate today by Sen. Edward M. Kennedy (D-MA). ANA views the bill as a critical first step toward ANA"s goal of ensuring guaranteed, affordable, high-quality health care for all.
Mental Health

Southampton Asthma Researchers Win Share Of EU Grant, UK

Southampton researchers studying the treatment of severe asthma have won a share of a 23m euro grant. Experts at the city"s Respiratory Biomedical Research Unit (BRU), based at Southampton General Hospital, are among a consortium of 14 European academic centres of excellence to receive a slice of the funding. The BRU, a partnership between Southampton University Hospitals NHS Trust and the University of Southampton, will use its share to pursue research into severe asthma, using methods developed in Southampton"s renowned lipid and protein research centres. The funding comes as part of a major investment drive by the European Union called Innovative Medicines Initiative (IMI), which is designed to remove bottlenecks in the discovery and development of new drugs. The project means that, for the first time, academics will work closely and comprehensively with pharmaceutical companies and enterprises to quickly progress drug development. Professor Ratko Djukanovic, director of the Southampton National Institute for Health Research BRU, was one of three initiators of the programme. He said: "Academics from different universities often work together to complement expertise and enhance research projects, but this is the first time they have joined forces with large pharma companies and enterprises to create a cohesive team. "Critically, the discoveries from this programme will be publicly owned and immediately made available for the benefit of all." The work to be conducted in Southampton will play a key role in the definition of new subsets of asthma and will take advantage of the state-of-the art research facilities on offer at the city"s university hospitals. Dr Michael Marsh, SUHT medical director, said: "The partnership between the Trust and the UoS is a real success, which is clear from our joint selection as venues for two leading BRUs, one in respiratory medicine and the other in nutrition. "Such status has enabled us to become part of this unique consortium and take a share of the research grant, making this Trust one of the best places for clinicians and scientists to work together for the direct benefit of patients." Professor Iain Cameron, head of the school of medicine, added: "This is a great achievement for Southampton. Not only does it reflect the excellent research conducted in Southampton, but also shows the benefits of close integration of scientists and clinicians across the University and SUHT and enhances our international reputation." Southampton University Hospitals NHS Trust


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009